期刊文献+

血浆ApoB水平与急性心肌梗死严重程度的相关性研究 被引量:2

下载PDF
导出
摘要 目的评估血浆ApoB水平与急性心肌梗死(AMI)严重程度的相关性。方法收集84例急性心肌梗死患者,依据血浆肌钙蛋白I(cTnI)水平将患者分为4组,比较各组患者血浆ApoB水平的高低,以及血浆ApoB水平与cTnI、糖化血红蛋白(GHbA1c)、三酰甘油(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)和超敏C反应蛋白(hs-CRP)水平的相关性。结果随着血浆cTnI水平升高,各组患者血浆ApoB水平也逐渐升高,差异有统计学意义(P<0.05)。采用Pearson相关分析提示,血浆CTnI水平与ApoB水平呈正相关,相关系数r=0.844(P<0.05);血浆GHbA1c、TG、TC、LDL-C和hs-CRP水平与ApoB水平呈正相关,而HDL-C则与ApoB水平呈负相关(P<0.05)。结论对于AMI患者,检测血浆ApoB水平,能够在一定程度上评估心肌细胞坏死的严重程度,具有一定的临床价值。
出处 《国际检验医学杂志》 CAS 2012年第12期1505-1506,共2页 International Journal of Laboratory Medicine
  • 相关文献

参考文献11

  • 1徐宝华,赵慧颖.动脉粥样硬化不稳定斑块的研究进展[J].心血管病学进展,2005,26(5):498-501. 被引量:23
  • 2Teramoto T,Sasaki J,Ueshima H,et al.Diagnostic criteria for dyslipidemia.Executive summary of Japan Atherosclerosis Society(JAS) guideline for diagnosis and prevention of atherosclerotic cardiovasculardiseases for Japanese[J].J Atheroscler Thrombo,2007,14(4):155-158.
  • 3黄宇理,包宗明,高大胜.急性冠脉综合征合并2型糖尿病临床分析[J].实用全科医学,2007,5(2):99-100. 被引量:15
  • 4Chenaud C,Merlani PG,Roux-Lombard P,et al.Low apolipoprotein AI level at intensive care unit admission and systemic inflammatory response syndrome exacerbation[J].Cri Care Med,2004,32(3):632-637.
  • 5Sierra-Johnson J,Romero-Corral A,Somers VK,et al.ApoB/ApoA-Ⅰ ratio:an independent predictor of insulin resistance in US non-diabetic subjects[J].Eur Heart J,2007,28(21):2637-2643.
  • 6van der Steeg WA,Boekholdt SM,Stein EA,et al.Role of the apolipoprotein B-apolipoprotein A-Ⅰ ratio in cardiovascular risk assessment:a case-control analysis in EPIC-Norfolk[J].Ann Intern Med,2007,146(9):640-648.
  • 7Saely CH,Koch L,Schmid F,et al.Lipoprotein(a),type 2 diabetes and vascular risk in coronary patients[J].Eur J Clin Invest,2006,36(2):91-97.
  • 8Walldius G,Jungner I.The apoB/apoA-I ratio:a strong,new risk factor for cardiovascular disease and a target for lipid-lowering therapy-a review of the evidence[J].J Intern Med,2006,259(5):493-519.
  • 9Lind L.Vasodilation in resistance arteries is related to the apolipoprotein B/A1 ratio in the elderly:the prospective investigation of the vasculature in uppsala seniors(PIVUS) study[J].Atherosclerosis,2007,190(2):378-384.
  • 10Walldius G,Jungner I,Holme I,et al.High apolipoprotein B,low apolipoprotein A-Ⅰ,and improvement in the prediction of fatal myocardial infarction(AMORIS study):a prospective study[J].Lancet,2001,358(9298):2026-2033.

二级参考文献40

  • 1李建军,李庚山.动脉粥样斑块破裂的研究进展[J].中华老年心脑血管病杂志,2000,2(4):273-278. 被引量:23
  • 2Cercek B,Yamashita M,Dimayuga P,et al.Nuclear factor-κB activity and arterial response to balloon injury[J].Atherosclerosis,1997,131:59-66.
  • 3Ridker PM,Rifai N,Pfeffer MA,et al.Inflammation,pravastatin,and the risk of coronary events after myocardial infarction in patients with average cholesterol levels[J].Circulation,1998,98:839-844.
  • 4George S,Abela MD,Paulo D,et al.Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model[J].Circulation,1995,91:776-784.
  • 5Mann JM,Davies MJ.Vulnerable plaque.Relation of characteristics to degree of stenosis in human coronary arteries[J].Circulation,1996,94(5):928-931.
  • 6Zhang SH,Reddick RL,et al.Spontaneous Hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E[J].Science,1992,258(10):468-471.
  • 7Bhatia V,Bhatia R.Imaging of the vulnerable plaque:new modalities[J].South Med J,2003,96(11):1142-1147.
  • 8Varnava AM,Mills PG,Davies MJ.Relationship between coronary artery remodeling and plaque vulnerability[J].Circulation,2002,105:939-959.
  • 9Moreno PR,Lodder RA.Detection of lipid pool,thin fibrous cap,and inflammatory cells in human aortic atherosclerotic plaques by near-infarcted spectroscopy[J].Circulation,2002,105:923.
  • 10Shah PK.Pathophysiology of coronary thrombosis:role of plaque rupture and plaque erosion[J].Prog Cardiovasc Dis,2002,44(5):357-368.

共引文献41

同被引文献23

  • 1中华医学会.临床诊疗指南·心血管分册[M].北京:人民卫生出版社,2008:70.
  • 2Parish S,Peto R,Palmer A,et al.The joint effects of apolipoprotein B,apolipoprotein A1,LDL cholesterol,and HDL cholesterol on risk:3510 cases of acute myocardial infarctionand 9805 controls[J].Eur Heart J,2009,30(17):2137.
  • 3Korita I,Buto A,Langlois M R,Verhoye E,et al.Serum amyloid A is independently related to apolipoprotein A-I but not to HDL-cholesterol in patients with angina pectoris[J].Clin Biochem,2013,46(16/17):1660.
  • 4Korita I,Buto A,Langlois M R,Verhoye E,et al.Serum amyloid A is independently related to apolipoprotein A-I but not to HDL-cholesterol in patients with angina pectoris[J].C lin Biochem,2013,46(16/17):1660.
  • 5Koenig W.High-sensitivity C-reactive protein and atherosclerotic disease:from improved risk prediction to riskguided therapy[J].Int J Cariol,2013,168(6):5126.
  • 6Tawfik MK, Ghattas MH, Abo-Elmatty DM, et al. Atorv- astatin restores the balance between pro-inflammatory and anti-inflammatory mediators in rats with acute myocardial infarction[J]. Eur Rev Pharmacol Sci, 2010,14 (6)..499- 506.
  • 7Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients[J]. Am J Cardiol, 1967,20(4) .. 457-464.
  • 8Renilla A, Barreiro M, Diaz E, et al. Impact o~ reper{usion strategy on outcomes in very elderly patients with acute myocardialin{arction[J3. Minerva Cardioangiol, 2014, 62 (6) :473-479.
  • 9Patti G, Chello M, Oatto L. et al. Short-term atorvastatin preload reduces levels of adhesion molecules in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Results from the ARMYDA-ACS CAMs(Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy [J]. J Cardiovase Med(Hagerstown), 2010,11 (11) : 795- 800.
  • 10肖祥彬,程希富,覃数,马康华.他汀类药物在心血管疾病中应用的研究进展[J].心血管病学进展,2008,29(4):647-650. 被引量:18

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部